PHENELZINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Phenelzine Sulfate patents expire, and what generic alternatives are available?
Phenelzine Sulfate is a drug marketed by Novel Labs Inc and is included in one NDA.
The generic ingredient in PHENELZINE SULFATE is phenelzine sulfate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenelzine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phenelzine Sulfate
A generic version of PHENELZINE SULFATE was approved as phenelzine sulfate by NOVEL LABS INC on December 8th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENELZINE SULFATE?
- What are the global sales for PHENELZINE SULFATE?
- What is Average Wholesale Price for PHENELZINE SULFATE?
Summary for PHENELZINE SULFATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 75 |
| Clinical Trials: | 4 |
| Patent Applications: | 2,017 |
| Drug Prices: | Drug price information for PHENELZINE SULFATE |
| What excipients (inactive ingredients) are in PHENELZINE SULFATE? | PHENELZINE SULFATE excipients list |
| DailyMed Link: | PHENELZINE SULFATE at DailyMed |
Recent Clinical Trials for PHENELZINE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Boehringer Ingelheim | Phase 1 |
| The Canberra Hospital | Phase 1 |
| Southern Medical Day Care Centre | Phase 1 |
Pharmacology for PHENELZINE SULFATE
| Drug Class | Monoamine Oxidase Inhibitor |
| Mechanism of Action | Monoamine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for PHENELZINE SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for PHENELZINE SULFATE
US Patents and Regulatory Information for PHENELZINE SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novel Labs Inc | PHENELZINE SULFATE | phenelzine sulfate | TABLET;ORAL | 200181-001 | Dec 8, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
